Revvity Inc (RVTY)
112.24
+1.13
(+1.02%)
USD |
NYSE |
Nov 22, 15:36
Revvity Total Liabilities (Quarterly): 4.848B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 4.848B |
June 30, 2024 | 5.555B |
March 31, 2024 | 5.586B |
December 31, 2023 | 5.692B |
September 30, 2023 | 5.727B |
June 30, 2023 | 6.349B |
March 31, 2023 | 6.604B |
December 31, 2022 | 6.747B |
September 30, 2022 | 6.759B |
June 30, 2022 | 7.023B |
March 31, 2022 | 7.662B |
December 31, 2021 | 7.859B |
September 30, 2021 | 7.941B |
June 30, 2021 | 4.500B |
March 31, 2021 | 4.760B |
December 31, 2020 | 4.225B |
September 30, 2020 | 3.634B |
June 30, 2020 | 3.669B |
March 31, 2020 | 3.625B |
December 31, 2019 | 3.725B |
September 30, 2019 | 3.782B |
June 30, 2019 | 3.692B |
March 31, 2019 | 3.448B |
December 31, 2018 | 3.391B |
September 30, 2018 | 3.290B |
Date | Value |
---|---|
June 30, 2018 | 3.441B |
March 31, 2018 | 3.571B |
December 31, 2017 | 3.588B |
September 30, 2017 | 2.203B |
June 30, 2017 | 2.166B |
March 31, 2017 | 2.132B |
December 31, 2016 | 2.123B |
September 30, 2016 | 2.169B |
June 30, 2016 | 2.106B |
March 31, 2016 | 2.161B |
December 31, 2015 | 2.056B |
September 30, 2015 | 1.977B |
June 30, 2015 | 1.962B |
March 31, 2015 | 1.968B |
December 31, 2014 | 2.085B |
September 30, 2014 | 1.824B |
June 30, 2014 | 1.881B |
March 31, 2014 | 1.942B |
December 31, 2013 | 1.952B |
September 30, 2013 | 1.932B |
June 30, 2013 | 1.951B |
March 31, 2013 | 1.974B |
December 31, 2012 | 1.962B |
September 30, 2012 | 1.948B |
June 30, 2012 | 1.916B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.625B
Minimum
Mar 2020
7.941B
Maximum
Sep 2021
5.624B
Average
5.639B
Median
Total Liabilities (Quarterly) Benchmarks
Bionano Genomics Inc | 38.49M |
Bruker Corp | 4.270B |
Azenta Inc | 331.07M |
Harvard Bioscience Inc | 65.92M |
Akoya Biosciences Inc | 116.34M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 12.77B |
Shareholders Equity (Quarterly) | 7.922B |
Debt to Equity Ratio | 0.4023 |
Current Ratio | 3.559 |
Net Debt Paydown Yield | 1.51% |